You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Go Write

    SBC: ATTAINMENT CO., INC.            Topic: 91990018R0006

    In this project, the team will develop a prototype of GoWrite, a platform designed for students with moderate to severe disabilities to guide instruction in writing. The cross-curricular intervention will have four modes including instruction, writing about academic content, journaling, and social media. At the end of Phase I, in a pilot study with 30 students (10 each in grade school, middle scho ...

    SBIR Phase I 2018 Department of EducationInstitute of Education Sciences
  2. A Novel, Nanostructured, Metal-organic Frameworks-Based Product Loss Prevention Technology in the Oil and Natural Gas Sector

    SBC: FRAMERGY INC            Topic: 17NCER2C

    To reach the end user, oil and gas production at the wellhead must be transmitted through the country and distributed to a wide range of customers. This logistical system requires natural gas gathering lines, processing facilities, product storage tanks and lots of other equipment. What results is air pollution caused by industry losses during these operations and the use of continuous or intermit ...

    SBIR Phase I 2018 Environmental Protection Agency
  3. Topic 380- QIDS: Using Radiomics to Impact Radiotherapy Treatment Planning- Moonshot

    SBC: HealthMyne, Inc.            Topic: NCI

    HealthMyne proposes developing a Clinical Decision Support tool to be used in the point-of-care workflow for the Radiation Oncologist that uses radiomic features that have evidence-based association to disease course and/or normal organ damage, in order to impact the treatment planning process. Phase 1 will focus on extraction, calculation, and validation of identified radiomic features for lung c ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  4. A High-Throughput, Multi-Omic Assay of Tumor Biomarkers from Single-Cells

    SBC: ISOPLEXIS CORPORATION            Topic: 172

    SUMMARY Although solid tumors oftentimes arise from the uninhibited growth of a single aberrant cellthe population of cells within a tumor are genetically and molecularly heterogenousThis makes it very difficult to evaluate a therapy s efficacy when using bulk population measurementsFurthermorerecent research has implicated microRNAsmiRNAsas drivers of progression and malignancy in many tumor type ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  5. Development of a cell based assay to assess antigen specific tolerance

    SBC: SALUS DISCOVERY LLC            Topic: R

    Project Summary Despite advances in the field of transplantation that have curbed acute rejection through immunosuppressive drugs and better control of infection and ischemia reperfusion injurychronic allograft rejection is still a major obstacle for successful organ transplantationSuccessful organ transplantation appears to require a balanced function of effector and regulatory T cellsTregto prev ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  6. Synthetic hydrogels for biomanufacturing of iPSC-derived neural cells for precision medicine

    SBC: STEM PHARM, INCORPORATED            Topic: 106

    Project Summary Abstract Human neural cells manufactured using patient derived induced pluripotent stem cellsiPSCshold great promise for modeling neurodevelopmental disordersdiscovering new precision therapiesand screening for potential risks from environmental toxinsHoweverbiomanufacturing of neural cells and tissues is severely limited by low efficiencypoor reproducibilityand extended timeframes ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  7. RAPID: An Extremely Fast Monte Carlo Dose Computing Software for Nuclear Medicine

    SBC: VOXIMETRY INC            Topic: 100

    PROJECT SUMMARY and ABSTRACT The clinical outcome of radiation therapy depends on delivering the highest possible absorbed dose to the tumor swhile limiting the dose to normal tissuesUnfortunatelyunlike external beam radiotherapyEBRTcurrent RT prescription methods do not consider absorbed dose to individual patients but instead use empirically derived or standard methodsThusup toof these patients ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. A Novel Myeloperoxidase Inhibitor for Treating Multiple Sclerosis

    SBC: ReNeuroGen LLC            Topic: 102

    Abstract Multiple sclerosisMSis an inflammatory demyelinating disease of the central nervous systemCNSIt is the most common autoimmune disease affecting the CNSAlthough much attention has focused on the immunological mechanisms in MSnew evidence suggests that oxidative stress also induces MS neuropathologyMyeloperoxidaseMPOis a powerful peroxidative enzyme that has long been considered a therapeut ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Selection and Development of a Lead Biologic for Treating Mitochondrial Disorders

    SBC: CYTEGEN CORP            Topic: NIA

    Project Summary Abstract Mitochondrial dysfunction causes mitochondrial diseases and is tightly linked to aging and neurodegenerative disorders such as Parkinsonandapos s and Alzheimerandapos sRecent discoveries support that mitochondrial dysfunction can be overcome to treat age related declineCyteGenandapos s hypothesis is that exercise induces the secretion of bloodborne proteins that act system ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  10. A 3-month Release Naltrexone for Addiction Treatment

    SBC: Plumb Pharmaceuticals LLC            Topic: NIDA

    Opioid misuse is a world wide problemand it is increasingThe epidemic has shifted from a problem largely confined to urban areas to one that is both urban and ruralMaintenance therapy helps alleviate situational cravings and makes addiction therapy more effectivebut methadone clinics are largely confined to larger citiesbuprenorphine must be prescribed by physicians with a specific waiverand it ma ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government